| |
I hope I find you in good health. One of the most distressing things
I have experienced as a doctor has been to explain to my patient that they have
lost their sight. Also explaining that there is nothing that can be done by anyone
to reverse this situation. This is one the most agonizing illness to be experienced
by anyone and yet this is exactly what happens with cytomegalovirus (CMV) infection.
The cytomegalovirus is related to the herpes virus and is present in almost
everyone. It is one of the most common types of virus that infects those who are
living positively. Normally, most people's immune systems are able to fight the
virus, preventing it from causing problems in their bodies. However, when the
immune system is suppressed because of AIDS, organ or bone marrow transplant,
or chemotherapy, the CMV virus can cause damage and disease to the eye and the
rest of the body. CMV retinitis, is nowadays one of the most common severe
infection affecting the eye in patients with late-stage AIDS. The disease typically
occurs during the late stages of AIDS when individuals have a T cell , or CD4
count, of less than 100. Left untreated, CMV can take a person's sight within
two to six months. In the past, about one-fourth of active AIDS patients developed
CMV retinitis. However, this figure appears to be dropping thanks to a potent
combination of antiretroviral, drugs which help restore the function of the immune
system. CMV retinitis is caused by the cytomegalovirus, a very common virus:
about 80% of adults harbor antibodies to CMV, which indicates their bodies have
successfully fought it off. The difference for people who have AIDS is that their
weakened or non-functioning immune system cannot stave off this virus.
CMV
retinitis may affect one eye at first, but usually progresses to both eyes and
becomes worse as the patient's ability to fight infection decreases. Patients
with CMV retinitis are at risk of retinal detachment, haemorrhages, and inflammation
of the retina that can lead to permanent loss of vision and even blindness. CMV
retinitis usually causes symptoms, but not always. Patients with any condition
that suppresses the immune system should watch for the following eye symptoms
while under the care of a physician, seeing moving black spots known as "floaters,"
(spots, bugs, spider webs),light flashes, blind spots, blurred vision, obstructed
areas of vision and sudden decrease or loss of vision. The eyes can also become
painful or red or become sensitive to light (photophobia) These symptoms may not
necessarily mean that you have CMV retinitis. However, if you experience one or
more of these symptoms, contact your doctor for a complete exam. CMV retinitis
is diagnosed through a standard eye examination. Dilation of the pupils and indirect
ophthalmoscopy will show signs of CMV retinitis. The objective of treatment
is to prevent progression of the disease, which can lead to blindness. Therapy
must be continued indefinitely, or until blindness occurs. Intravenous ganciclovir,
foscarnet, and cidofovir have all been shown to improve CMV retinitis. Once
the patient is improving, the drugs can sometimes be taken orally instead. Sometimes,
however, CMV is resistant to these drugs. Also, ganciclovir can deplete white
blood cells, and cidofovir and foscarnet can cause kidney damage.
The
biggest treatment breakthrough is highly active antiretroviral therapy (HAART),
a combination of drugs that suppress the human immunodeficiency virus (HIV), also
known as the AIDS virus. HAART allows your immune system to recover and fight
off infections like CMV retinitis. Your doctor may suggest you continue taking
anti-CMV drugs for the first three months or so of HAART, sometimes patients'
immune response improves right away, but CMV retinitis takes a little longer. Symptomatic
CMV infection normally occurs only in immunocompromised individuals. Avoiding
the primary cause of immune deficiency, AIDS, will therefore prevent symptomatic
CMV infection. Progression of the disease is common, even when therapy continues,
because antiviral medications stop the replication of the virus but do not destroy
it. CMV is itself immunosuppressive and may worsen the symptoms of other causes
of immunosuppression. Routine eye check by the doctor is very important especially
for those patients with a CD4 count below 50. If the disease is picked up early
then intervention to delay progression to blindness will also be done early. Till
next week take care of yourself and each other. Remember, "
. in all
your getting, get understanding." Also, ganciclovir can deplete white
blood cells, and cidofovir and foscarnet can cause kidney damage. The biggest
treatment breakthrough is highly active antiretroviral therapy (HAART), a combination
of drugs that suppress the human immunodeficiency virus (HIV), also known as the
AIDS virus. HAART allows your immune system to recover and fight off infections
like CMV retinitis. Your doctor may suggest you continue taking anti-CMV drugs
for the first three months or so of HAART, sometimes patients' immune response
improves right away, but CMV retinitis takes a little longer. Symptomatic CMV
infection normally occurs only in immunocompromised individuals. Avoiding the
primary cause of immune deficiency, AIDS, will therefore prevent symptomatic CMV
infection. Progression of the disease is common, even when therapy continues,
because antiviral medications stop the replication of the virus but do not destroy
it. CMV is itself immunosuppressive and may worsen the symptoms of other causes
of immunosuppression. Routine eye check by the doctor is very important especially
for those patients with a CD4 count below 50. If the disease is picked up early
then intervention to delay progression to blindness will also be done early. Till
next week take care of yourself and each other. Remember, "
. in all
your getting, get understanding." Dr
P. Chimedza is a medical practitioner with a special interest in HIV and AIDS.
Information for this article was researched from different medical textbooks,
medical journals and other medical information sources for which this author hereby
acknowledges. This column is kindly sponsored by Generation Health. For further
information on this topic and suggestions on future topics for discussion you
can mail him on pchimedza@hotmail.com.
|